MINDACT, the first clinical trial to be run under the TRANSBIG umbrella and coordinated by the EORTC, has a distinct budget that includes participation of Commercial Partners such as
Agendia, Novartis, Hoffmann- La Roche, Sanofi-Aventis, and support from national cancer organisations such as
Fondation contre le Cancer /Stichting tegen Kanker for Belgium.